Pulmonary Hypertension Secondary to Myxomatous Mitral Valve Disease in Dogs: Current Insights into the Histological Manifestation and Its Determining Factors

被引:2
作者
Grzeczka, Arkadiusz [1 ]
Paslawska, Urszula [2 ]
Graczyk, Szymon [1 ]
Antosik, Paulina [3 ]
Zawadzki, Marcin [1 ]
Paslawski, Robert [4 ]
机构
[1] Nicolaus Copernicus Univ, Inst Vet Med, Fac Biol & Vet Sci, Dept Basic & Preclin Sci, PL-87100 Torun, Poland
[2] Nicolaus Copernicus Univ, Inst Vet Med, Fac Biol & Vet Sci, Dept Diagnost & Clin Sci, PL-87100 Torun, Poland
[3] Nicolaus Copernicus Univ, Coll Med Bydgoszcz, Dept Clin Pathomorphol, PL-85094 Bydgoszcz, Poland
[4] Nicolaus Copernicus Univ, Inst Vet Med, Fac Biol & Vet Sci, Dept Vet Surg, PL-87100 Torun, Poland
来源
APPLIED SCIENCES-BASEL | 2024年 / 14卷 / 06期
关键词
endothelin; nitric oxide; serotonin; myxomatous mitral valve disease; pulmonary vessels; pulmonary; ENDOTHELIAL GROWTH-FACTOR; CELL DISTRIBUTION WIDTH; KING CHARLES SPANIELS; PROTEIN-KINASE-C; NITRIC-OXIDE; HEART-FAILURE; SEROTONIN TRANSPORTER; ARTERIAL-HYPERTENSION; VASCULAR REACTIVITY; SIGNAL-TRANSDUCTION;
D O I
10.3390/app14062577
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Pulmonary venous hypertension (PVH) is caused by deteriorating left ventricular function. The most common cause of PVH in dogs is myxomatous mitral valve degeneration (MMVD). It causes left ventricular volume overload and an increase in left atrial and pulmonary venous pressure (PVH), which leads to pulmonary vascular wall remodeling and contributes to the perpetuation and worsening of PVH. Pulmonary vascular wall remodeling is also characteristic of pulmonary arterial hypertension (PAH). However, the changes in PVH arise secondary to heart failure and vascular remodeling progresses as the disease progresses. On the other hand, PAH is a primary disease that can be triggered, for example, by the use of certain drugs. Similar structural changes may suggest the influence of similar pathophysiological mechanisms or the intermediation of similar mediators. Therefore, this article discusses recent and hitherto uncommented findings elucidating the pathophysiology of the processes and influences on the pattern of histological changes observed in pulmonary hypertension secondary to degenerative mitral valve disease. In particular, we focus on the activity of factors such as endothelin, serotonin, and nitric oxide, which are involved in pulmonary vascular wall remodeling in both PVH and PAH.
引用
收藏
页数:15
相关论文
共 138 条
  • [1] Elevated plasma tyrosine kinases VEGF-D and HER4 in heart failure patients decrease after heart transplantation in association with improved haemodynamics
    Ahmed, Salaheldin
    Ahmed, Abdulla
    Saleby, Joanna
    Bouzina, Habib
    Lundgren, Jakob
    Radegran, Goran
    [J]. HEART AND VESSELS, 2020, 35 (06) : 786 - 799
  • [2] Serum Serotonin Concentrations in Dogs with Degenerative Mitral Valve Disease
    Arndt, J. W.
    Reynolds, C. A.
    Singletary, G. E.
    Connolly, J. M.
    Levy, R. J.
    Oyama, M. A.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2009, 23 (06): : 1208 - 1213
  • [3] Transcriptome-wide analysis associates ID2 expression with combined pre- and post-capillary pulmonary hypertension
    Arwood, Meghan J.
    Vahabi, Nasim
    Lteif, Christelle
    Sharma, Ravindra K.
    Machado, Roberto F.
    Duarte, Julio D.
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [4] Bacakova L., 2018, ROLE VASCULAR SMOOTH, DOI [10.5772/intechopen.77115, DOI 10.5772/INTECHOPEN.77115]
  • [5] Fenfluramine potentiates canine pulmonary vasoreactivity to endothelin-1
    Barman, SA
    Isales, CM
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 1998, 11 (2-3) : 183 - 187
  • [6] Canine pulmonary vasoreactivity to serotonin: Role of protein kinase C and tyrosine kinase
    Barman, SA
    Pauly, JR
    Isales, CM
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (02): : H740 - H747
  • [7] Prevalence and Prognostic Importance of Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease
    Borgarelli, M.
    Abbott, J.
    Braz-Ruivo, L.
    Chiavegato, D.
    Crosara, S.
    Lamb, K.
    Ljungvall, I.
    Poggi, M.
    Santilli, R. A.
    Haggstrom, J.
    [J]. JOURNAL OF VETERINARY INTERNAL MEDICINE, 2015, 29 (02): : 569 - 574
  • [8] Vascular Endothelial Growth Factor D, Pulmonary Congestion, and Incidence of Heart Failure
    Borne, Yan
    Gransbo, Klas
    Nilsson, Jan
    Melander, Olle
    Orho-Melander, Marju
    Smith, J. Gustav
    Engstrom, Gunnar
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (05) : 580 - 582
  • [9] Plasma nitric oxide in dogs with pulmonary hypertension secondary or not to left-sided heart disease
    Braz, J. B.
    Beluque, T.
    Ampuero, R. A. N.
    Canola, R. A. M.
    Batalhao, M. . E.
    Carnio, E. C.
    Camacho, A. A.
    [J]. ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA, 2023, 75 (02) : 161 - 173
  • [10] Selected hematological, biochemical, and echocardiographic variables as predictors of survival in canine patients with myxomatous mitral valve disease and congestive heart failure
    Brloznik, M.
    Pecjak, A.
    Svete, A. Nemec
    Petric, A. Domanjko
    [J]. JOURNAL OF VETERINARY CARDIOLOGY, 2023, 46 : 18 - 29